Evaluation of stem cell marker gene expression in canine prostate carcinoma- and prostate cyst-derived cell lines

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Autoren

  • Mohammed Moulay
  • Wen Liu
  • Saskia Willenbrock
  • Katharina Anna Sterenczak
  • Regina Carlson
  • Anaclet Ngezahayo
  • Hugo Murua Escobar
  • Ingo Nolte

Externe Organisationen

  • Stiftung Tierärztliche Hochschule Hannover
Forschungs-netzwerk anzeigen

Details

OriginalspracheEnglisch
Seiten (von - bis)5421-31
Seitenumfang11
FachzeitschriftAnticancer research
Jahrgang33
Ausgabenummer12
PublikationsstatusVeröffentlicht - Dez. 2013

Abstract

BACKGROUND/AIM: In human prostate cancer cells with a stem cell-like character (cancer stem cells, CSC) are considered to play a major role in disease development, progression and relapse. Aim of the study was to evaluate if similar cells are present and active in canine prostate cancer providing a naturally-occurring mammalian model for the development of therapeutic approaches targeting CSC.

MATERIALS AND METHODS: Stem cell marker expression of CD133, CD44, C-KIT, CD34, ITGA6, OCT4, DDX5 and MELK in canine prostate carcinomas and prostate cyst cell lines were screened by Polymerase Chain Reaction (PCR), quantitative Polymerase Chain Reaction (qPCR) and partially analysed by flow cytometry.

RESULTS: Marker analyses by PCR and qPCR, revealed a complex expression pattern for the analysed marker genes, providing a characteristic marker pattern for the studied cell lines. Thereby CD44, CD133, ITGA6 and DDX5 showed the most prominent expression in the analysed cell lines.

CONCLUSION: The results revealed a characteristic stem cell marker expression in the analysed cell lines, indicating the presence of CSC in canine prostate cancer.

Ziele für nachhaltige Entwicklung

Zitieren

Evaluation of stem cell marker gene expression in canine prostate carcinoma- and prostate cyst-derived cell lines. / Moulay, Mohammed; Liu, Wen; Willenbrock, Saskia et al.
in: Anticancer research, Jahrgang 33, Nr. 12, 12.2013, S. 5421-31.

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Moulay, M, Liu, W, Willenbrock, S, Sterenczak, KA, Carlson, R, Ngezahayo, A, Murua Escobar, H & Nolte, I 2013, 'Evaluation of stem cell marker gene expression in canine prostate carcinoma- and prostate cyst-derived cell lines', Anticancer research, Jg. 33, Nr. 12, S. 5421-31. https://doi.org/doi: 10.1016/j.yexcr.2013.03.016
Moulay, M., Liu, W., Willenbrock, S., Sterenczak, K. A., Carlson, R., Ngezahayo, A., Murua Escobar, H., & Nolte, I. (2013). Evaluation of stem cell marker gene expression in canine prostate carcinoma- and prostate cyst-derived cell lines. Anticancer research, 33(12), 5421-31. https://doi.org/doi: 10.1016/j.yexcr.2013.03.016
Moulay M, Liu W, Willenbrock S, Sterenczak KA, Carlson R, Ngezahayo A et al. Evaluation of stem cell marker gene expression in canine prostate carcinoma- and prostate cyst-derived cell lines. Anticancer research. 2013 Dez;33(12):5421-31. doi: doi: 10.1016/j.yexcr.2013.03.016
Moulay, Mohammed ; Liu, Wen ; Willenbrock, Saskia et al. / Evaluation of stem cell marker gene expression in canine prostate carcinoma- and prostate cyst-derived cell lines. in: Anticancer research. 2013 ; Jahrgang 33, Nr. 12. S. 5421-31.
Download
@article{9a73d176e5eb4247b13b406a4ccc825d,
title = "Evaluation of stem cell marker gene expression in canine prostate carcinoma- and prostate cyst-derived cell lines",
abstract = "BACKGROUND/AIM: In human prostate cancer cells with a stem cell-like character (cancer stem cells, CSC) are considered to play a major role in disease development, progression and relapse. Aim of the study was to evaluate if similar cells are present and active in canine prostate cancer providing a naturally-occurring mammalian model for the development of therapeutic approaches targeting CSC.MATERIALS AND METHODS: Stem cell marker expression of CD133, CD44, C-KIT, CD34, ITGA6, OCT4, DDX5 and MELK in canine prostate carcinomas and prostate cyst cell lines were screened by Polymerase Chain Reaction (PCR), quantitative Polymerase Chain Reaction (qPCR) and partially analysed by flow cytometry.RESULTS: Marker analyses by PCR and qPCR, revealed a complex expression pattern for the analysed marker genes, providing a characteristic marker pattern for the studied cell lines. Thereby CD44, CD133, ITGA6 and DDX5 showed the most prominent expression in the analysed cell lines.CONCLUSION: The results revealed a characteristic stem cell marker expression in the analysed cell lines, indicating the presence of CSC in canine prostate cancer.",
keywords = "Animals, Base Sequence, Biomarkers/metabolism, Cell Line, Cysts/genetics, DNA Primers, Dogs, Gene Expression, Male, Prostatic Diseases/genetics, Prostatic Neoplasms/genetics, Real-Time Polymerase Chain Reaction, Stem Cells/metabolism",
author = "Mohammed Moulay and Wen Liu and Saskia Willenbrock and Sterenczak, {Katharina Anna} and Regina Carlson and Anaclet Ngezahayo and {Murua Escobar}, Hugo and Ingo Nolte",
year = "2013",
month = dec,
doi = "doi: 10.1016/j.yexcr.2013.03.016",
language = "English",
volume = "33",
pages = "5421--31",
journal = "Anticancer research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "12",

}

Download

TY - JOUR

T1 - Evaluation of stem cell marker gene expression in canine prostate carcinoma- and prostate cyst-derived cell lines

AU - Moulay, Mohammed

AU - Liu, Wen

AU - Willenbrock, Saskia

AU - Sterenczak, Katharina Anna

AU - Carlson, Regina

AU - Ngezahayo, Anaclet

AU - Murua Escobar, Hugo

AU - Nolte, Ingo

PY - 2013/12

Y1 - 2013/12

N2 - BACKGROUND/AIM: In human prostate cancer cells with a stem cell-like character (cancer stem cells, CSC) are considered to play a major role in disease development, progression and relapse. Aim of the study was to evaluate if similar cells are present and active in canine prostate cancer providing a naturally-occurring mammalian model for the development of therapeutic approaches targeting CSC.MATERIALS AND METHODS: Stem cell marker expression of CD133, CD44, C-KIT, CD34, ITGA6, OCT4, DDX5 and MELK in canine prostate carcinomas and prostate cyst cell lines were screened by Polymerase Chain Reaction (PCR), quantitative Polymerase Chain Reaction (qPCR) and partially analysed by flow cytometry.RESULTS: Marker analyses by PCR and qPCR, revealed a complex expression pattern for the analysed marker genes, providing a characteristic marker pattern for the studied cell lines. Thereby CD44, CD133, ITGA6 and DDX5 showed the most prominent expression in the analysed cell lines.CONCLUSION: The results revealed a characteristic stem cell marker expression in the analysed cell lines, indicating the presence of CSC in canine prostate cancer.

AB - BACKGROUND/AIM: In human prostate cancer cells with a stem cell-like character (cancer stem cells, CSC) are considered to play a major role in disease development, progression and relapse. Aim of the study was to evaluate if similar cells are present and active in canine prostate cancer providing a naturally-occurring mammalian model for the development of therapeutic approaches targeting CSC.MATERIALS AND METHODS: Stem cell marker expression of CD133, CD44, C-KIT, CD34, ITGA6, OCT4, DDX5 and MELK in canine prostate carcinomas and prostate cyst cell lines were screened by Polymerase Chain Reaction (PCR), quantitative Polymerase Chain Reaction (qPCR) and partially analysed by flow cytometry.RESULTS: Marker analyses by PCR and qPCR, revealed a complex expression pattern for the analysed marker genes, providing a characteristic marker pattern for the studied cell lines. Thereby CD44, CD133, ITGA6 and DDX5 showed the most prominent expression in the analysed cell lines.CONCLUSION: The results revealed a characteristic stem cell marker expression in the analysed cell lines, indicating the presence of CSC in canine prostate cancer.

KW - Animals

KW - Base Sequence

KW - Biomarkers/metabolism

KW - Cell Line

KW - Cysts/genetics

KW - DNA Primers

KW - Dogs

KW - Gene Expression

KW - Male

KW - Prostatic Diseases/genetics

KW - Prostatic Neoplasms/genetics

KW - Real-Time Polymerase Chain Reaction

KW - Stem Cells/metabolism

U2 - doi: 10.1016/j.yexcr.2013.03.016

DO - doi: 10.1016/j.yexcr.2013.03.016

M3 - Article

C2 - 24324078

VL - 33

SP - 5421

EP - 5431

JO - Anticancer research

JF - Anticancer research

SN - 0250-7005

IS - 12

ER -

Von denselben Autoren